Endoscopic dilatation/incision of primary obstructive megaureter. A systematic review. On behalf of the EAU paediatric urology guidelines panel.

Endoscopic management Pediatric urology Primary obstructive megaureter Systematic review

Journal

Journal of pediatric urology
ISSN: 1873-4898
Titre abrégé: J Pediatr Urol
Pays: England
ID NLM: 101233150

Informations de publication

Date de publication:
13 Sep 2023
Historique:
received: 16 02 2023
revised: 23 08 2023
accepted: 06 09 2023
medline: 28 9 2023
pubmed: 28 9 2023
entrez: 27 9 2023
Statut: aheadofprint

Résumé

Historically, ureteral reimplantation (UR) has been the gold standard for treatment of primary obstructive megaureter (POM) with declining renal function, worsening obstruction, or recurrent urinary tract infections. In infants, open surgery with reimplantation of a grossly dilated ureter into a small bladder, can be technically challenging with significant morbidity. Therefore, less invasive endoscopic management such as dilatation or incision of the ureter-vesical junction, has emerged as an alternative to reimplantation during the last decades. To systematically evaluate the effectivity, safety, and potential benefits of endoscopic treatment (dilatation with or without balloon or incision) of POM in comparison to UR. A systematic review was conducted. Randomized controlled trials (RCTs), nonrandomized comparative studies (NRSs), and single-arm case series including a minimum of 20 participants and a mean follow-up more than 12 months were eligible for inclusion. Of 504 articles identified, 8 articles including 338 patients were eligible for inclusion (0 RCTs, 1 NRSs, and 7 case series). Age at time of surgery was minimum 15 days to a maximum of 192 months. Indications for endoscopic treatment (ET) included patients with loss of split renal function (>10%) and worsening of hydroureteronephrosis. The studies analysed reported a success rate ranging from 35% to 97%. Success was defined as stabilization of differential renal function without further procedures. A post-operative complication rate of 23-60% was reported (mostly transient haematuria, urinary tract infections and stent migration or intolerance). In 14% of the cases salvage UR following initial ET, was performed due to relapse of symptomatic POM. Endoscopic treatment for persistent or progressive POM in children is a minimally invasive alternative to UR with a long-term modest success rate. Additionally, it can be performed within a wide age span, with equal success rate and complication rates.

Identifiants

pubmed: 37758534
pii: S1477-5131(23)00404-7
doi: 10.1016/j.jpurol.2023.09.005
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest None.

Auteurs

Martin Skott (M)

Department of Urology, Section of Pediatric Urology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: martinskott24@gmail.com.

Michele Genech (M)

Department of Paediatric Urology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: michele.gnech@policlinico.mi.it.

Lisette A 't Hoen (LA')

Department of Pediatric Urology, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: l.thoen@erasmusmc.nl.

Uchenna Kennedy (U)

Department of Pediatric Urology, University Children's Hospital Zurich, Switzerland. Electronic address: Uchenna.Kennedy@kispi.uzh.ch.

Allon Van Uitert (A)

Department of Urology, Radboud University Medical Centre, Nijmegen, the Netherlands. Electronic address: Allon.vanUitert@radboudumc.nl.

Alexandra Zachou (A)

Department of HIV and Sexual Health, Chelsea & Westminster Hospital, London, United Kingdom. Electronic address: zachoual@gmail.com.

Yuhong Yuan (Y)

Department of Medicine, McMaster University, Hamilton, ON, Canada. Electronic address: yyuan@mcmaster.ca.

Josine Quaedackers (J)

Department of Urology and Pediatric Urology, University Medical Center Gronningen, Rijks University Groningen, Groningen, the Netherlands. Electronic address: j.s.l.t.quaedackers@umcg.nl.

Mesrur Selcuk Silay (MS)

Division of Pediatric Urology, Department of Urology, Istanbul Birurni University, Istanbul, Turkey. Electronic address: selcuksilay@gmail.com.

Yazan F Rawashdeh (YF)

Department of Urology, Section of Pediatric Urology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: yazan.rawashdeh@rm.dk.

Berk Burgu (B)

Department of Pediatric Urology, Ankara University School of Medicine, Ankara, Turkey. Electronic address: berkburgu@gmail.com.

Marco Castagnetti (M)

Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padua, Italy. Electronic address: marco.castagnetti@unipd.it.

Fardod O'Kelly (F)

Division of Paediatric Urology, Beacon Hospital, Dublin, Ireland, University College Dublin, Ireland. Electronic address: fardod.okelly@ucd.ie.

Guy Bogaert (G)

Department of Urology, University of Leuven, Leuven, Belgium. Electronic address: guy.bogaert@uzleuven.be.

Christian Radmayr (C)

Department of Urology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: christian.radmayr@i-med.ac.at.

Classifications MeSH